52 Week Range
As of on the NASDAQ ∙ Minimum 15 minute delay
3M AVG Volume
52 Week High
52 Week Low
Shares Out (MIL)
Market Cap (MIL)
Dividend (Yield %)
Medidata Reports Q2 Non-GAAP EPS $0.48 Excluding Items
Catalyst Launches New Multi-solution CRO Powered by the Medidata Rave Clinical Cloud
Phastar Says Enters Technology Partnership With Medidata
Medidata Solutions Inc. (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company's plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments. Study Design Optimization enables customers to gain visibility into the impact of protocol elements on resource and trial endpoints. Grants Manager compares specific industry benchmarks and analytics, using industry's database of negotiated procedure costs, to support appropriate grants to investigator sites and automated negotiations with multiple investigator sites. Payments enables customers to establish a global investigator payment strategy and process to automate payment calculation, distribution and reporting, including tax and currency exchange calculations.
Software & Programming
350 Hudson St Fl 9
Tarek A. Sherif
Chairman of the Board, Chief Executive Officer
Glen M. de Vries
Chief Financial Officer
Michael I. Otner
Executive Vice President, General Counsel, Corporate Secretary
Michael Christopher Pray
Executive Vice President, General Manager - Global Sales
Price To Earnings (TTM)
Price To Sales (TTM)
Price To Book (MRQ)
Price To Cash Flow (TTM)
Total Debt To Equity (MRQ)
LT Debt To Equity (MRQ)
Return on Investment (TTM)
Return on Equity (TTM)
The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:
France's Dassault Systemes moved to build up its life sciences presence with a $5.8 billion cash deal to buy Medidata Solutions, a U.S. firm focused on clinical trials.
French technology company Dassault Systemes said it had agreed to buy Medidata Solutions, a U.S. software company dealing in the sphere of clinical trials, in a deal worth $5.8 billion on an enterprise value basis.
French technology company Dassault Systemes SE is nearing a deal to acquire U.S.-based software firm for clinical trials Medidata Solutions Inc to boost its life sciences unit, CNBC reported on Tuesday, citing people familiar with the matter.
French technology company Dassault Systemes SE is nearing a deal to acquire U.S.-based software firm clinical trials Medidata Solutions Inc, CNBC reported on Tuesday, citing people familiar with the matter.
* Q1 EARNINGS PER SHARE VIEW $0.35 -- THOMSON REUTERS I/B/E/S
* MEDIDATA REPORTS RECORD FULL-YEAR AND FOURTH QUARTER 2017 RESULTS
* Q3 revenue $140.1 million versus I/B/E/S view $141.4 million
* Worldwide Clinical Trials selects Medidata to streamline clinical site reimbursements across the globe Source text for Eikon: Further company coverage:
* Q1 revenue $126.8 million versus I/B/E/S view $125.4 million
* Medidata reports record full-year and fourth quarter 2016 results
* Q3 earnings per share view $0.26 -- Thomson Reuters I/B/E/S
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.